title: Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety.
authors.forename: D A
authors.initials: DA
authors.lastname: Vorchheimer
authors.forename: V
authors.initials: V
authors.lastname: Fuster
mesh_terms: D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex